Variant report
Variant | nsv964044 |
---|---|
Chromosome Location | chr4:45007652-45034467 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr4:45015052-45015122 | K562 | blood: | n/a | n/a |
2 | FOS | chr4:45024485-45024504 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | KAP1 | chr4:45023149-45023590 | K562 | blood: | n/a | n/a |
4 | MAFK | chr4:45012771-45012884 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | MAZ | chr4:45023070-45023202 | HepG2 | liver: | n/a | n/a |
6 | MXI1 | chr4:45022238-45022259 | GM12878 | blood: | n/a | n/a |
7 | MXI1 | chr4:45030005-45030140 | GM12878 | blood: | n/a | n/a |
8 | NRF1 | chr4:45014963-45014989 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr4:45031022-45031113 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr4:45016278-45016354 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr4:45025040-45025174 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr4:45033908-45034397 | H1-neurons | neurons: | n/a | n/a |
13 | POLR2A | chr4:45015875-45015887 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr4:45009439-45009558 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr4:45011228-45011320 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | TCF7L2 | chr4:45015216-45016023 | HepG2 | liver: | n/a | chr4:45015653-45015669 chr4:45015654-45015668 |
17 | ZMIZ1 | chr4:45013967-45014055 | K562 | blood: | n/a | n/a |
18 | ZNF143 | chr4:45032350-45032540 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:44999456..45001286-chr4:45006123..45008246,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248744 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6821483 | chr4:45007652-45007653 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs371465001 | chr4:45007709-45007710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6852218 | chr4:45007837-45007838 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs141718770 | chr4:45007846-45007847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538556877 | chr4:45007864-45007865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10009882 | chr4:45007873-45007874 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs74839475 | chr4:45007882-45007883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536284767 | chr4:45007931-45007932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554585704 | chr4:45007937-45007938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373109500 | chr4:45007948-45007949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572998743 | chr4:45007952-45007953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150595437 | chr4:45007959-45007960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558896968 | chr4:45007969-45007970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552116028 | chr4:45007978-45007979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs66749922 | chr4:45008032-45008033 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs527389930 | chr4:45008038-45008039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544478037 | chr4:45008047-45008048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563236603 | chr4:45008089-45008090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4632690 | chr4:45008090-45008091 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs541842851 | chr4:45008135-45008136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs36116617 | chr4:45008154-45008155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4492035 | chr4:45008165-45008166 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs4385111 | chr4:45008185-45008186 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs556842315 | chr4:45008229-45008230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138634014 | chr4:45008238-45008239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564419310 | chr4:45008255-45008256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568460223 | chr4:45008257-45008258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532375576 | chr4:45008276-45008277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149572335 | chr4:45008334-45008335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569200765 | chr4:45008384-45008385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146058484 | chr4:45008455-45008456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79876337 | chr4:45008457-45008458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115948036 | chr4:45008479-45008480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367608994 | chr4:45008481-45008482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372799465 | chr4:45008504-45008505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548226045 | chr4:45008513-45008514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7660094 | chr4:45008537-45008538 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs143705013 | chr4:45008562-45008563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35422539 | chr4:45008571-45008572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113162464 | chr4:45008594-45008595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7665240 | chr4:45008624-45008625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576855266 | chr4:45008666-45008667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538466458 | chr4:45008713-45008714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368425662 | chr4:45008763-45008764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs60306865 | chr4:45008764-45008765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397953402 | chr4:45008785-45008786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556309923 | chr4:45008792-45008793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554215557 | chr4:45008813-45008814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148565410 | chr4:45008853-45008854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142911642 | chr4:45008867-45008868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:45006200-45008400 | Enhancers | HMEC | breast |
2 | chr4:45006200-45008600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:45007400-45012800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr4:45007400-45012800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:45009400-45009800 | Enhancers | Fetal Heart | heart |
6 | chr4:45012800-45014400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr4:45012800-45015200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:45013000-45014400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr4:45013600-45014200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr4:45013800-45014000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:45015000-45015400 | Enhancers | Primary hematopoietic stem cells | blood |
12 | chr4:45029200-45029400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr4:45029400-45035800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr4:45031000-45031200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr4:45031200-45031800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr4:45031800-45032200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr4:45031800-45032400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr4:45032200-45038400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
19 | chr4:45032400-45038600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
20 | chr4:45033200-45035800 | Enhancers | Fetal Heart | heart |
21 | chr4:45034200-45034400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |